Tag: BEST-CLI
New data and heated debates set to spark controversy in CX...
“These will be important, salutary lessons. Should a controversy arise again involving a proven efficacious therapy, we now know that stopping access to that...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
Vascular News 101 – February 2024: North American Edition
In this issue:
LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Could metformin be first-ever medical treatment that is effective...
Vascular News 101 – February 2024: European Edition
In this issue:
LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Could metformin be first-ever medical treatment that is effective...
Vascular News’ top 10 most popular stories of January 2024
January's top 10 highlights new guidelines from the European Society for Vascular Surgery (ESVS), an expert consensus roundtable on the benefits of intravascular ultrasound...
BEST-CLI: One year on
A dedicated session at the 2023 VEITHsymposium (14–18 November, New York, USA) aimed to unpack the ways in which clinical practice and attitudes in...
Vascular News’ top 10 most popular stories of June 2023
Highlights from this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2023; 14–17 June, National Harbor, USA) feature prominently in June's top 10.
1. “Sonolysis...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
“A very grey area”: EVOCC trial addresses best treatment option for...
Athanasios Saratzis (University of Leicester, Leicester, UK) speaks to Vascular News about the EVOCC trial, which he hopes will dispel patient and physician “uncertainty”...
Vascular News’ top 10 most popular stories of November 2022
November's top 10 includes the first results from BEST-CLI, as well as new data presented at this year's Vascular Interventional Advances (VIVA; 31 October–3...
First data from BEST-CLI bring surgical bypass into the forefront of...
The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
BEST-CLI attracts US$3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a US$3.3 million contribution toward the BEST-CLI (Best endovascular versus best surgical therapy in patients with critical limb...
“On the descending curve”: BEST-CLI rises to COVID-19 and financial challenges
Vascular News spoke to the principal investigators of the BEST-CLI (Best endovascular versus best surgical therapy in critical limb ischaemia) trial—Alik Farber (Boston Medical...
BEST-CLI trial enrolment nears halfway mark
As the second year of enrolment draws to a close, the Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI)...
